April 19, 2013
The Food and Drug Administration left medicines on the market for years after discovering they were approved based on fraudulent studies by Cetero Research, which did testing for drug companies worldwide.
Stories this photo appears in:
Health Care
Double Dose: In Second Case of Flawed Drug Research, FDA Response Was Slow and Secretive
The FDA found that data produced from 2000 through 2004 at two MDS facilities in Quebec, Canada, were questionable.
Comments
Use the comment form below to begin a discussion about this content.
comments powered by Disqus